Ostos, Rizza .
HRN: 26-79-02 Sex: FemalePatient Encounter
AMS Audit List
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/08/2025
METRONIDAZOLE 500MG (TAB)
03/09/2025
03/15/2025
ORAL
500mg
TID
S/P LTCS
Waiting Final Action